Overview

Preliminary Study of Pharmacokinetics of Ginkgolides Meglumine Injection.

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
To explore the rule of absorption, distribution, metabolism and elimination after intravenous administration of Ginkgolides Meglumine Injection healthy subjects. The plasma drug profiles will be important to assess the potential clinical drug-drug interactions.
Phase:
Phase 4
Details
Lead Sponsor:
Jiangsu Kanion Pharmaceutical Co., Ltd
Collaborator:
Beijing Bionovo Medicine Development Co., Ltd.